Previous work in our laboratory has shown that palmatine treatment can inhibit trigeminal neuralgia, which may be related to the down-regulation of the expression of BDNF and CGRP in trigeminal ganglion neurons (He et al., 2020; Liu et al., 2020a). Here, BDNF is linked to trigeminal nerve disorder.